Home » Clinical Trials » Search Clinical Trials

Last updated on November 2019

Dose Optimization Study of Idelalisib in Follicular Lymphoma

Brief description of study

The primary objective of this study is to establish a safe and effective dosing regimen of idelalisib in participants with relapsed or refractory follicular lymphoma (FL) who have no other therapeutic options.

Clinical Study Identifier: NCT02536300

Start Over

Pacific Shores Medical Group

Long Beach, CA United States

St. Luke's Mountain States Tumor Institute (MSTI) - Boise

Boise, ID United States

McFarland Clinic PC - Ames - 1215 Duff Avenue Office

Ames, IA United States

IHA Hematology Oncology Consultants

Ypsilanti, MI United States

North Shore Hematology Oncology Associates, PLLC

Stony Brook, NY United States

Kaiser Permanente Medical Center, Northwest Region

Portland, OR United States

St Vincent's Public Hospital Sydney

Darlinghurst, Australia

The Tweed Hospital

Tweed Heads, Australia

Calvary Hospital

North Adelaide, Australia

Box Hill Hospital

Box Hill, Australia

Peninsula & South Eastern Haematology and Oncology Group

Frankston, Australia

Royal Perth Hospital

Perth, Australia

Alfred Health

Melbourne, Australia

Cross Cancer Institute

Edmonton, AB Canada

Fraser Clinical Trials, Inc

New Westminster, BC Canada

Royal Victoria Regional Health Centre

Barrie, ON Canada

Centre Hospitalier Affilie Universitaire de Quebec

Quebec, QC Canada

Fakultni Nemocnice Brno

Brno, Czechia

Fakultni nemocnice Kralovske Vinohrady

Praha, Czechia

University Hospital Motol

Praha, Czechia

Centre Hospitalier Victor Dupouy d'Argenteuil

Argenteuil, France

Centre Hospitalier d'Avignon-Hopital Henri Duffaut

Avignon, France

Centre Hospitalier Le Mans

Le Mans, France

Hopital Saint Antoine

Paris Cedex 12, France

Hopital Saint Louis

Paris Cedex 12, France

Centre L on B rard - Centre de Lutte contre le Cancer

Pierre Bénite Cedex, France

Centre Hospitalier Lyon Sud

Pierre Bénite Cedex, France

C.H.U. de Poitiers

Poitiers Cedex, France

Centre Hospitalier Regional et Univeritaire de Tours

Tours, France

Carmel Medical Center

Haifa, Israel

Meir Medical Center

Kfar Saba, Israel

Azienda Ospedaliera Papa Giovanni XXIII

Bergamo, Italy

Azienda Ospedaliera Spedali Civili di Brescia

Brescia, Italy

IRCCS Ospedale San Raffaele

Milano, Italy

Azienda Ospedaliera Vincenzo Cervello

Palermo, Italy

Azienda Ospedaliero Universitaria di Parma

Parma, Italy

Azienda Ospedaliera Citt della Salute e della Scienza di Torino

Torino, Italy

Azienda Ospedaliero-Universitaria di Udine

Udine, Italy

Szpital Specjalistyczny w Brzozowie Podkarpacki Osrodek Onkologiczny im. Ks. B. Markiewicza

Brzozow, Poland

Szpitale Wojew dzkie w Gdyni sp lka z ograniczona odpowiedzialnoscia

Gdynia, Poland

Malopolskie Centrum Medyczne S.C.

Kraków, Poland

Samodzielny Publiczny Szpital Kliniczny Nr 1

Lublin, Poland

Samodzielny Publiczny Zaklad Oieki Zdrowotnej

Olsztyn, Poland

Centrum Onkologii - Instytut im Marii Sklodowskiej-Curie

Warszawa, Poland

Medical University Wroclaw

Wroclaw, Poland

Spitalul Judetean de Urgenta Dr.Constantin Opris Baia Mare

Baia Mare, Romania

Spitalul Clinic Coltea

Bucuresti, Romania

Institutul Oncologic Prof. Dr. Ion Chiricuta Cluj Napoca

Cluj-Napoca, Romania

Institutul Regional De Oncologie IASI

Iasi, Romania

Hospital del Mar

Barcelona, Spain

Institut Catala d'Oncologia

L'Hospitalet de Llobregat, Spain

Centro Integral Oncologico Clara Campal (CIOCC)

Madrid, Spain

Fundacion Jimenez Diaz

Madrid, Spain

Hospital General Universitario Gregorio Maranon

Madrid, Spain

Hospital Universitario Puerta de Hierro

Madrid, Spain

Hospital Universitario Ramon y Cajal

Madrid, Spain

Hospital Son Llatzer

Palma de Mallorca, Spain

Hospital Universitari Politecnic La Fe de Valencia

Valencia, Spain

Kent and Canterbury Hospital

Canterbury, United Kingdom

Hillingdon Hospital

London, United Kingdom

Royal Oldham Hospital

Oldham, United Kingdom

University Hospitals Birmingham NHS Foundation Trust

Birmingham, United Kingdom

Northwick Park Hospital

Harrow, United Kingdom

Raigmore Hospital

Inverness, United Kingdom

Barts Health NHS Trust

London, United Kingdom

Imperial College Healthcare NHS Trust Hammersmith Hospital

London, United Kingdom

St George's Healthcare NHS Trust

London, United Kingdom

University College London

London, United Kingdom

Centre L on B rard - Centre de Lutte contre le Cancer

Pierre Bénite Cedex, France

Centre Hospitalier Lyon Sud

Pierre Bénite Cedex, France

Malopolskie Centrum Medyczne S.C.

Kraków, Poland

McFarland Clinic PC

Ames, IA United States

Hematology Oncology Clinic

Baton Rouge, LA United States

Hematology Oncology Consultants

Ypsilanti, MI United States

North Shore Hematology Oncology Associates

Stony Brook, NY United States

Fakultni nemocnice Kralovske Vinohrady

Prague, Czechia

Centre L on B rard - Centre de Lutte contre le Cancer

Pierre Bénite Cedex, France

Centre Hospitalier Lyon Sud

Pierre Bénite Cedex, France

A.S.U. Integrata Santa Maria della Misericordia

Udine, Italy

Malopolskie Centrum Medyczne S.C.

Kraków, Poland

Instytut Hematologii i Transfuzjologii, Klinika Hematologii

Warszawa, Poland

Uniwersytecki Szpital Kliniczny im. Jana Mikulicza-Radeckiego we Wroclawiu

Wroclaw, Poland

Dose Optimization Study of Idelalisib in Follicular Lymphoma

Brief description of study

Volunteer Sign-up